Panacea Biotec Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
835.46 Cr.
|
P/BV
|
1.02
|
Book Value (Rs.)
|
134.19
|
52 Week High/Low (Rs.)
|
203/114
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 612.51 | 612.51 | 612.51 | 612.51 | 612.51 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 |
Preference Share Capital | 4.98 | 4.15 | 3.45 | 2.90 | 10.54 |
Total Share Capital | 11.11 | 10.27 | 9.57 | 9.02 | 16.67 |
| | | | | |
Reserves and Surplus | 815.82 | 842.67 | -256.47 | 138.87 | 334.63 |
Total Reserves and Surplus | 815.82 | 842.67 | -256.47 | 138.87 | 334.63 |
Money Received Against Share Warrants | 0.00 | 0.00 | 0.00 | 32.00 | 0.00 |
Total Shareholders Funds | 826.93 | 852.94 | -246.90 | 179.89 | 351.30 |
Hybrid/Debt/Other Securities | 21.65 | 0.00 | 21.65 | 21.79 | 9.64 |
Minority Interest | -3.49 | -2.98 | -3.00 | -3.04 | -3.01 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 15.18 | 29.96 | 731.63 | 610.23 | 35.58 |
Deferred Tax Liabilities [Net] | 20.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Long Term Liabilities | 32.14 | 70.59 | 194.41 | 83.48 | 3.97 |
Long Term Provisions | 26.55 | 29.24 | 55.36 | 42.74 | 39.78 |
Total Non-Current Liabilities | 94.24 | 129.78 | 981.40 | 736.45 | 79.33 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 0.06 | 0.05 | 0.00 | 3.57 | 69.39 |
Trade Payables | 177.32 | 259.78 | 221.94 | 198.85 | 269.71 |
Other Current Liabilities | 118.31 | 530.55 | 190.37 | 245.83 | 592.72 |
Short Term Provisions | 36.14 | 12.39 | 13.35 | 6.96 | 6.44 |
Total Current Liabilities | 331.83 | 802.77 | 425.66 | 455.21 | 938.26 |
| | | | | |
Total Capital And Liabilities | 1271.17 | 1782.51 | 1178.82 | 1390.30 | 1375.52 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 588.33 | 587.81 | 606.65 | 655.52 | 803.11 |
Intangible Assets | 11.62 | 1.47 | 2.05 | 1.86 | 2.46 |
Capital Work-In-Progress | 28.01 | 4.91 | 21.24 | 9.51 | 8.39 |
Intangible Assets Under Development | 14.32 | 12.35 | 13.18 | 14.50 | 14.12 |
Fixed Assets | 642.28 | 606.54 | 643.12 | 681.39 | 828.07 |
Non-Current Investments | 0.07 | 0.07 | 0.07 | 5.58 | 5.33 |
Deferred Tax Assets [Net] | 0.00 | 30.17 | 0.15 | 1.95 | 19.79 |
Long Term Loans And Advances | 0.30 | 0.00 | 1.22 | 1.21 | 1.17 |
Other Non-Current Assets | 60.20 | 105.17 | 23.29 | 16.90 | 13.28 |
Total Non-Current Assets | 702.85 | 741.96 | 667.84 | 707.03 | 867.63 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 13.42 | 5.00 | 0.00 | 0.00 | 0.00 |
Inventories | 202.09 | 212.72 | 174.14 | 147.69 | 81.43 |
Trade Receivables | 60.09 | 131.66 | 84.68 | 68.52 | 88.73 |
Cash And Cash Equivalents | 225.99 | 583.28 | 135.79 | 89.75 | 23.48 |
Short Term Loans And Advances | 1.58 | 1.44 | 4.29 | 4.36 | 18.13 |
OtherCurrentAssets | 65.15 | 106.45 | 112.06 | 372.96 | 296.12 |
Total Current Assets | 568.32 | 1040.55 | 510.97 | 683.27 | 507.89 |
| | | | | |
Total Assets | 1271.17 | 1782.51 | 1178.82 | 1390.30 | 1375.52 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 644.43 | 373.48 | 413.45 | 368.66 | 407.73 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |